Apple Inc. (AAPL), BioDelivery Sciences International Inc. (BDSI) Among Thomas Bailard’s Top Q2 Top Picks

Thomas Bailard is the co-founder and current manager of Bailard Inc. Located in California, Bailard uses quantitative and fundamental analyses to choose its investments. In its latest 13F filing, Bailard Inc. has disclosed a total of 235 positions as of the end of the second quarter of 2014. The value of the fund’s equity portfolio amounted to $650.1 million, up from $630.5 million reported as at the end of the previous quarter.

AAPL Apple Store

From the Bailard’s equity portfolio, we have picked top five holdings, in term of value. The first on the list is Apple Inc. (NASDAQ:AAPL), in which the fund boosted its position to 84,196 shares, worth $7.82 million, from 9,142 shares. For its fiscal 2014 third quarter ended June 28, 2014, Apple Inc. (NASDAQ:AAPL) reported revenue of $37.4 billion, compared to $35.3 billion in the year-ago quarter. Its quarterly net profit was $7.7 billion, or $1.28 per diluted share, compared to net profit of $6.9 billion, or $1.07 per diluted share, in the same quarter of 2013. Among other shareholders of Apple Inc. (NASDAQ:AAPL) include David Einhorn‘s Greenlight Capital and Natixis Global Asset Management‘s Harris Associates, holding 1.99 million shares and 1.56 million shares, respectively.

Bailard revealed upping its stake in BioDelivery Sciences International Inc. (NASDAQ:BDSI) to 398,000 shares, with a reported value of $4.80 million. Previously, the fund reported ownership of 342,400 shares of the company. BioDelivery Sciences International Inc. (NASDAQ:BDSI) is a specialty pharmaceutical company focusing in the areas of pain management and addiction medicine, has a market cap of $622.01 million. Aside from Bailard, Deerfield Management, led by James E. Flynn, owns 3.99 million shares of BioDelivery Sciences International Inc. (NASDAQ:BDSI) and Kevin Kotler’s Broadfin Capital holds 3.47 million shares.

The third position is held by Johnson & Johnson (NYSE:JNJ), in which the fund disclosed a $4.36 million stake, which contains 41,638 shares. The stake represents an increase from 39,373 the fund held previously. Recently, Johnson & Johnson (NYSE:JNJ), which is engaged in the research and development and sale of health care products, announced that its board of directors approved the repurchase of up to $5 billion of the company’s common stock. Other significant shareholders of Johnson & Johnson (NYSE:JNJ) include Ken Fisher’s Fisher Asset Management, owning 9.98 million shares, and Donald Yacktman’s Yacktman Asset Management, holding 9.57 million shares of the company.

In Chevron Corporation (NYSE:CVX), Bailard disclosed holding 30,575 shares, with a reported value of $3.99 million. The stake is up from 29,138 the fund held earlier. Chevron Corporation (NYSE:CVX) is an integrated energy company having a market cap of $248.60 billion. Last month, the company’s subsidiary Chevron Global Energy Inc. announced the sale of its 25% non-operated interest in a producing oil concession in southern Chad and the related export pipeline interests to the Republic of Chad for about $1.3 billion. In addition to Bailard, other shareholders of the company include Ken Fisher’s Fisher Asset Management, owning 3.50 million shares, according to our record. Another investor, Adage Capital Management, managed by Phill Gross and Robert Atchinson, revealed owning 2.73 million shares of Chevron Corporation (NYSE:CVX).

On the fifth spot is Enanta Pharmaceuticals Inc. (NASDAQ:ENTA), in which the fund increased its position to 91,500 shares, worth $3.94 million, from 74,306 shares. Enanta Pharmaceuticals Inc. (NASDAQ:ENTA) is a research and development-focused biotechnology company. For the fiscal second quarter ended March 31, 2014, the company reported revenue of $2.2 million, compared to $1.2 million for the same period of 2013. It reported a net loss of $5.2 million, compared to a net loss of $3.7 million for the same quarter last year. The shareholders of the company, in addition to Bailard, include Peter Kolchinsky’s RA Capital Management and Mitchell Blutt’s Consonance Capital Management, holding 1.54 million and 1.25 million shares of the company, respectively.

Disclosure: none

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

6 Ways to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

The Most Heartwarming and Inspirational Story Of This Halloween Season, It Will Make You Cry and Jump For Joy

10 Best Party Songs of All Time to Bring the House Down With

5 New World Order Conspiracy Theories that Will Strangle the World

The 10 Highest Rated Movies of 2014

The 10 Largest Container Shipping Companies in the World

The 10 Largest Armies in the World: Who Should We Be Afraid Of?

Best Warren Buffett Quotes on Money You Need to Hear

The 10 Highest Suicide Rates by Profession

The 20 Most Underrated Movies of All Time

The 10 Fastest Growing Companies in America

The 10 Biggest Outlet Malls in USA

The 5 Most Popular Rap Songs of All Time

The 10 Countries that Eat the Most Meat

The10 Most Expensive Countries to Fly To

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!